Pharmapprove Aug 1, 2011 - Apr 2016
President and Chief Scientific Officer
Nda Group Ab Aug 1, 2011 - Apr 2016
Chief Operating and Chief Scientific Officer
Phytomedics Apr 2008 - Jun 2011
President and Chief Executive Officer
Bristol-Myers Squibb Jul 2004 - Jul 2007
Vice President Corporate Business Risk Management
Bristol-Myers Squibb Jun 1997 - Jul 2004
Senior Vice President Global Regulatory Science
Education:
Yale School of Medicine 1975 - 1979
Doctor of Medicine, Doctorates
Fordham University 1971 - 1975
Bachelors, Bachelor of Arts, Biology
Skills:
Drug Development Oncology Biotechnology Pharmaceutical Industry Infectious Diseases Healthcare Strategy Clinical Trials Clinical Development Pharmacology Diabetes Fda Biopharmaceuticals Research Cro Regulatory Affairs Immunology Medicine Regulatory Strategy Lifesciences Regulatory Submissions Strategic Communications Vaccines Gcp Drug Discovery Toxicology Market Access Pharmaceuticals Project Management Medical Devices 21 Cfr Part 11 Medical Writing Ctms Neurology Technology Transfer Life Sciences Drug Product Drug Development All Disease Areas Medical Specialty Oncology U.s. Food and Drug Administration Good Clinical Practice
Interests:
Education Environment Science and Technology Human Rights Health
Laurie Smaldone Md
Biotechnology Professional
Phyromedics Mar 2008 - May 2011
President and Chief Executive Officer
Bristol-Myers Squibb Jul 1985 - Jul 2007
Vice President Corporate Business Risk Management;Svp Global Regulatory Science; Vice President Infectious Disease
Education:
Yale School of Medicine 1975 - 1984
Doctor of Medicine, Doctorates, Medicine